How much funding has Brinter raised?

Brinter has raised $1.5M in total funding, most recently a Seed round.

Who are Brinter's investors?

Brinter's investors include Innovestor.

Where is Brinter headquartered?

Brinter is headquartered in Santa Monica, California, United States.

What industry is Brinter in?

Brinter operates in Healthcare.

Brinter

Orthopedics today, organs tomorrow

Santa Monica, United States · Founded 2024 · $1.5M raised

Healthcare

Headquarters: Santa Monica, California
Founded: 2024
Business Model: B2B
Website: brinter.com

Total Funding: $1.5M
Last Round: $1.5M SeedJun 2021
Rounds: 1

About

Brinter is an American-Finnish biotech firm developing 3D bioprinted regenerative tissue implants for orthopedic and aesthetic medical applications. The company's flagship product is a tendon and ligament implant on track to become the world's first 3D-bioprinted orthopedic implant to reach commercial use. Brinter's implants are bioresorbable and engineered with biomimetic architecture and bioactive materials to support the body's natural healing cascade. The company's patented 3D bioprinter-powered manufacturing automation platform enables scalable, high-performance mass production of medical devices. Applications include orthopedic soft-tissue repair and aesthetic procedures, with a longer-term vision for organ printing.

Summary

Brinter is a Healthcare company based in Santa Monica, United States, founded in 2024. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Jun 2021. Investors include Innovestor.